AAAAAA

   
Results: 1-19 |
Results: 19
P53 - AN ACROBAT IN TUMORIGENESIS
Authors: MOLL UM SCHRAMM LM
Citation: Um. Moll et Lm. Schramm, P53 - AN ACROBAT IN TUMORIGENESIS, Critical reviews in oral biology and medicine, 9(1), 1998, pp. 23-37
EXPRESSION LEVEL, ALLELIC ORIGIN, AND MUTATION ANALYSIS OF THE P73 GENE IN NEUROBLASTOMA TUMORS AND CELL-LINES
Authors: KOVALEV S MARCHENKO N SWENDEMAN S LAQUAGLIA M MOLL UM
Citation: S. Kovalev et al., EXPRESSION LEVEL, ALLELIC ORIGIN, AND MUTATION ANALYSIS OF THE P73 GENE IN NEUROBLASTOMA TUMORS AND CELL-LINES, Cell growth & differentiation, 9(11), 1998, pp. 897-903
LOSS OF P53 FUNCTION IN UTERINE PAPILLARY SEROUS CARCINOMA
Authors: KOVALEV S MARCHENKO ND GUGLIOTTA BG CHALAS E CHUMAS J MOLL UM
Citation: S. Kovalev et al., LOSS OF P53 FUNCTION IN UTERINE PAPILLARY SEROUS CARCINOMA, Human pathology, 29(6), 1998, pp. 613-619
FUNCTIONAL HISTOLOGY OF THE NEUROENDOCRINE THYMUS
Authors: MOLL UM
Citation: Um. Moll, FUNCTIONAL HISTOLOGY OF THE NEUROENDOCRINE THYMUS, Microscopy research and technique, 38(3), 1997, pp. 300-310
CLOSTRIDIUM-PERFRINGENS SEPTICEMIA WITH MASSIVE HEMOLYSIS IN A PATIENT WITH HODGKINS LYMPHOMA
Authors: SINGER AJ MIGDAL PM OKEN JP CHALE SN MOLL UM
Citation: Aj. Singer et al., CLOSTRIDIUM-PERFRINGENS SEPTICEMIA WITH MASSIVE HEMOLYSIS IN A PATIENT WITH HODGKINS LYMPHOMA, The American journal of emergency medicine, 15(2), 1997, pp. 152-154
MORPHOLOGIC EFFECTS OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER
Authors: MOLL UM CHUMAS J
Citation: Um. Moll et J. Chumas, MORPHOLOGIC EFFECTS OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BREAST-CANCER, Pathology research and practice, 193(3), 1997, pp. 187-196
ROLE OF P53 ALTERATION IN PRIMARY PERITONEAL CARCINOMA
Authors: MOLL UM VALEA F CHUMAS J
Citation: Um. Moll et al., ROLE OF P53 ALTERATION IN PRIMARY PERITONEAL CARCINOMA, International journal of gynecological pathology, 16(2), 1997, pp. 156-162
NUCLEAR OVEREXPRESSION OF P53 PROTEIN DOES NOT CORRELATE WITH GENE MUTATION IN PRIMARY PERITONEAL CARCINOMA
Authors: MARCHENKO ND MOLL UM
Citation: Nd. Marchenko et Um. Moll, NUCLEAR OVEREXPRESSION OF P53 PROTEIN DOES NOT CORRELATE WITH GENE MUTATION IN PRIMARY PERITONEAL CARCINOMA, Human pathology, 28(9), 1997, pp. 1002-1006
NO MUTATIONS WITHIN CONSERVED DOMAIN-I OF THE P53 GENE IN MEDULLARY-THYROID CANCER
Authors: LANG CH HERRMANN ME ELMAGHRABI MR ABUMRAD NN LANE MA BAUNOCH DA MOLL UM
Citation: Ch. Lang et al., NO MUTATIONS WITHIN CONSERVED DOMAIN-I OF THE P53 GENE IN MEDULLARY-THYROID CANCER, Oncology Reports, 3(2), 1996, pp. 269-271
CYTOPLASMIC SEQUESTRATION OF WILD-TYPE P53 PROTEIN IMPAIRS THE G(1) CHECKPOINT AFTER DNA-DAMAGE
Authors: MOLL UM OSTERMEYER AG HALADAY R WINKFIELD B FRAZIER M ZAMBETTI G
Citation: Um. Moll et al., CYTOPLASMIC SEQUESTRATION OF WILD-TYPE P53 PROTEIN IMPAIRS THE G(1) CHECKPOINT AFTER DNA-DAMAGE, Molecular and cellular biology, 16(3), 1996, pp. 1126-1137
DOUBLE MINUTES IN THE PAPILLARY THYROID-CANCER CELL-LINE PTC-1113A
Authors: HERRMANN ME LALLEY PA RYDSTEDT LL MEESE E LANG CH ABUMRAD NN MOLL UM TALPOS GB
Citation: Me. Herrmann et al., DOUBLE MINUTES IN THE PAPILLARY THYROID-CANCER CELL-LINE PTC-1113A, Cancer genetics and cytogenetics, 90(1), 1996, pp. 70-74
UTERINE PAPILLARY SEROUS CARCINOMA EVOLVES VIA A P53-DRIVEN PATHWAY
Authors: MOLL UM CHALAS E AUGUSTE M MEANEY D CHUMAS J
Citation: Um. Moll et al., UTERINE PAPILLARY SEROUS CARCINOMA EVOLVES VIA A P53-DRIVEN PATHWAY, Human pathology, 27(12), 1996, pp. 1295-1300
CYTOPLASMICALLY SEQUESTERED WILD-TYPE P53 PROTEIN IN NEUROBLASTOMA ISRELOCATED TO THE NUCLEUS BY A C-TERMINAL PEPTIDE
Authors: OSTERMEYER AG RUNKO E WINKFIELD B AHN B MOLL UM
Citation: Ag. Ostermeyer et al., CYTOPLASMICALLY SEQUESTERED WILD-TYPE P53 PROTEIN IN NEUROBLASTOMA ISRELOCATED TO THE NUCLEUS BY A C-TERMINAL PEPTIDE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15190-15194
P53 GENE ALTERATIONS IN DIFFERENTIATED THYROID CANCERS
Authors: HERRMANN ME BAUNOCH DA MALIARIK M KOST J LINDEN M LATIF NA LALLEY PA TALPOS GB KAPLAN EL THOMPSON NW RYDSTEDT LL MOLL UM TEWARI A LANE MA
Citation: Me. Herrmann et al., P53 GENE ALTERATIONS IN DIFFERENTIATED THYROID CANCERS, Oncology Reports, 2(5), 1995, pp. 741-747
P53 MEDIATED TUMOR-CELL RESPONSE TO CHEMOTHERAPEUTIC DNA-DAMAGE - A PRELIMINARY-STUDY IN MATCHED PAIRS OF BREAST-CANCER BIOPSIES
Authors: MOLL UM OSTERMEYER AG AHOMADEGBE JC MATHIEU MC RIOU G
Citation: Um. Moll et al., P53 MEDIATED TUMOR-CELL RESPONSE TO CHEMOTHERAPEUTIC DNA-DAMAGE - A PRELIMINARY-STUDY IN MATCHED PAIRS OF BREAST-CANCER BIOPSIES, Human pathology, 26(12), 1995, pp. 1293-1301
WILD-TYPE P53 PROTEIN UNDERGOES CYTOPLASMIC SEQUESTRATION IN UNDIFFERENTIATED NEUROBLASTOMAS BUT NOT IN DIFFERENTIATED TUMORS
Authors: MOLL UM LAQUAGLIA M BENARD J RIOU G
Citation: Um. Moll et al., WILD-TYPE P53 PROTEIN UNDERGOES CYTOPLASMIC SEQUESTRATION IN UNDIFFERENTIATED NEUROBLASTOMAS BUT NOT IN DIFFERENTIATED TUMORS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(10), 1995, pp. 4407-4411
PLASMA ASSAY OF GELATINASE-B - TISSUE INHIBITOR OF METALLOPROTEINASE COMPLEXES IN CANCER
Authors: ZUCKER S LYSIK RM DIMASSIMO BI ZARRABI HM MOLL UM GRIMSON R TICKLE SP DOCHERTY AJ
Citation: S. Zucker et al., PLASMA ASSAY OF GELATINASE-B - TISSUE INHIBITOR OF METALLOPROTEINASE COMPLEXES IN CANCER, Cancer, 76(4), 1995, pp. 700-708
POOR-PROGNOSIS OF P53 GENE MUTATION AND NUCLEAR OVEREXPRESSION OF P53PROTEIN IN INFLAMMATORY BREAST-CARCINOMA
Authors: RIOU G LE MG TRAVAGLI JP LEVINE AJ MOLL UM
Citation: G. Riou et al., POOR-PROGNOSIS OF P53 GENE MUTATION AND NUCLEAR OVEREXPRESSION OF P53PROTEIN IN INFLAMMATORY BREAST-CARCINOMA, Journal of the National Cancer Institute, 85(21), 1993, pp. 1765-1767
INHIBITION OF MATRIX METALLOPROTEINASE-9 ACTIVATION BY A SPECIFIC MONOCLONAL-ANTIBODY
Authors: RAMOSDESIMONE N MOLL UM QUIGLEY JP FRENCH DL
Citation: N. Ramosdesimone et al., INHIBITION OF MATRIX METALLOPROTEINASE-9 ACTIVATION BY A SPECIFIC MONOCLONAL-ANTIBODY, Hybridoma, 12(4), 1993, pp. 349-363
Risultati: 1-19 |